Search
Sysmex Europe
Europe | EN
Company
Company
Back
Company
Who is Sysmex?
Who is Sysmex?
Back
Sustainability
Sustainability
Back
Newsroom
Newsroom
Back
Contacts
Contacts
Back
Products
Products
Back
Products
Diagnostics
Diagnostics
Back
Life Science
Life Science
Back
Flow cytometry
Flow cytometry
Back
Solution Provision
Solution Provision
Back
Services
Services
Back
Services
Consulting
Consulting
Back
QC & Online Services
QC & Online Services
Back
Document Centre
Document Centre
Back
Academy
Academy
Back
Academy
Knowledge Centre
Knowledge Centre
Back
Clinic & Laboratory
Clinic & Laboratory
Back
Training
Training
Back
Library
Library
Back
Career
Career
Back
Career
About Sysmex Europe GmbH
About Sysmex Europe GmbH
Back
Why work with us at Sysmex?
Why work with us at Sysmex?
Back
Join Sysmex now!
Join Sysmex now!
Back
Menu

Headquarters

Subsidiaries, Associated Foundation

Select your local website

Please select your country. This will keep you up to date with your country-specific information.

Thank you for visiting our poster session at ESMO-GI 2019

RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC)

 

 

Author: Yu Sunakawa1, Masato Nakamura2, Masahiro Ishizaki3, Masato Kataoka4, HironagaSatake5, Masaki Kitazono6, Hideyuki Yanagisawa7, Yasuyuki Kawamoto8, Hidekazu Kuramochi9, Hisatsugu Ohori10, Michio Nakamura11, Keita Takahashi12, Fumiyo Maeda13, Chihiro Komeno14, Masahiro Takeuchi15, Masashi Fujii16, Takayuki Yoshino17, WataruIchikawa18, and Akihito Tsuji19

 

Download poster

Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos

SCIENTIFIC LITERATURE

See our collection

JOIN OUR TEAM

Find your job